Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep-Oct;19(5):459-65.
doi: 10.1016/j.bjid.2015.06.001. Epub 2015 Jun 26.

Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species

Affiliations

Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species

Raimunda Sâmia Nogueira Brilhante et al. Braz J Infect Dis. 2015 Sep-Oct.

Abstract

The antifungal activity of some statins against different fungal species has been reported. Thus, at the first moment, the in vitro antifungal activity of simvastatin, atorvastatin and pravastatin was tested against Candida spp. and Cryptococcus spp. Then, in a second approach, considering that the best results were obtained for simvastatin, this drug was evaluated in combination with antifungal drugs against planktonic growth and tested against biofilms of Candida spp. and Cryptococcus spp. Drug susceptibility testing was performed using the microdilution broth method, as described by the Clinical and Laboratory Standards Institute. The interaction between simvastatin and antifungals against planktonic cells was analyzed by calculating the fractional inhibitory concentration index. Regarding biofilm susceptibility, simvastatin was tested against growing biofilm and mature biofilm of one strain of each tested yeast species. Simvastatin showed inhibitory effect against Candida spp. and Cryptococcus spp. with minimum inhibitory concentration values ranging from 15.6 to 1000 mg L(-1) and from 62.5 to 1000 mg L(-1), respectively. The combination of simvastatin with itraconazole and fluconazole showed synergism against Candida spp. and Cryptococcus spp., while the combination of simvastatin with amphotericin B was synergistic only against Cryptococcus spp. Concerning the biofilm assays, simvastatin was able to inhibit both growing biofilm and mature biofilm of Candida spp. and Cryptococcus spp. The present study showed that simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species.

Keywords: Antifungal activity; Biofilm; Candida; Cryptococcus; Simvastatin.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
In vitro effect of simvastatin (SIM), amphotericin B (AMB), and itraconazole (ITC) at 3 different concentrations on biofilm formation (A) and mature biofilm (B) of Candida spp. Black bars: positive control; MIC: minimum inhibitory concentration. Absorbance of XTT (492 nm). *Represents statistically significant difference (p < 0.05) when compared to the positive control. Data expressed as mean ± SEM.
Fig. 2
Fig. 2
In vitro effect of simvastatin (SIM), amphotericin B (AMB), and itraconazole (ITC) at 3 different concentrations on biofilm formation (A) and mature biofilm (B) of Cryptococcus spp. strains. Black bars: positive control; MIC, minimum inhibitory concentration. Absorbance of XTT (492 nm). *Represents statistical significant difference (p < 0.05) when compared to the positive control. Data expressed as mean ± SEM.

References

    1. Santos E.R., Dal Forno C.F., Hernandez M.G., et al. Susceptibility of Candida spp. isolated from blood cultures as evaluated using the M27-A3 and new M27-S4 approved breakpoints. Rev Inst Med Trop Sao Paulo. 2014;56:477–482. - PMC - PubMed
    1. Martins N., Ferreira I.C.F.R., Barros L., Silva S., Henriques M. Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment. Mycopathologia. 2014;177:223–240. - PubMed
    1. Martins M.A., Brighente K.B.S., Matos T.A., Vidal J.E., Hipólito D.D.C., Pereira-Chioccola V.L. Molecular diagnosis of cryptococcal meningitis in cerebrospinal fluid: comparison of primer sets for Cryptococcus neoformans and Cryptococcus gattii species complex. Braz J Infect Dis. 2015;19:62–67. - PMC - PubMed
    1. Sloan D.J., Parris V. Criptococcal meningitis: epidemiology and therapeutic options. Clin Epidemiol. 2014;6:169–182. - PMC - PubMed
    1. Pfaller M.A., Boyken L., Hollis R.J., Messer S.A., Tendolkar S., Diekema D.J. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance. J Clin Microbiol. 2006;44:760–763. - PMC - PubMed

Publication types